{"product_id":"nyu-langone-health-cardiac-amyloidosis-diagnosis-and-novel-therapeutics-in-2024","title":"NYU Langone Health Cardiac Amyloidosis Diagnosis and Novel Therapeutics in 2024","description":"\u003ch3\u003eNYU Langone Health Cardiac Amyloidosis Diagnosis and Novel Therapeutics in 2024\u003c\/h3\u003e\n\u003cstrong\u003e Include: 1 video + 17 pdfs, size: 13.5 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: cardiologists, internists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv id=\"activityInfo\"\u003eNYU Langone Health, 550 First Ave New York, NY United States\u003cbr\u003e\u003cspan class=\"datetime\"\u003e\u003cspan class=\"date\"\u003eSeptember 19, 2024\u003c\/span\u003e \u003cspan class=\"time\"\u003e8:00 AM – 5:30 PM\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv id=\"activityText\"\u003e\n\u003cdiv class=\"activityDescription\"\u003eThis is a live and virtual course designed for cardiologists, internists, nurse practitioners, nurses, physician assistants, and anyone who cares for patients with different types of amyloidosis. The majority of the speakers form part of our multidisciplinary amyloidosis team. There will be an emphasis on cardiac manifestations of amyloidosis, and experts in the fields of cardiac imaging, electrophysiology, and advanced heart failure and transplantation will discuss new diagnostic and therapeutic options. There will also be educational sessions on the neurologic, gastrointestinal, renal, and musculoskeletal manifestations of amyloidosis. Our experts in the AL Amyloidosis and Multiple Myeloma Program will provide an update on AL amyloidosis and ongoing clinical trials.\u003c\/div\u003e\n\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"objectives\"\u003e\n\u003cbr\u003e\u003cbr\u003eAfter participating in this activity, clinicians should be able to:\u003cbr\u003e\u003col\u003e\n\u003cli\u003eExplain the advantages and disadvantages of different imaging techniques that can be used in the diagnosis and monitoring of cardiac amyloidosis\u003c\/li\u003e\n\u003cli\u003eDescribe treatment options under investigation for amyloidosis\u003c\/li\u003e\n\u003cli\u003eRecognize potential barriers and learn about the process on creating an amyloidosis program\/clinic\u003c\/li\u003e\n\u003cli\u003eIdentify patients who would benefit from advanced heart failure therapies including heart transplantation\u003c\/li\u003e\n\u003cli\u003eDescribe new treatment (e.g., pacing) strategies in patients with conduction system disease and atrial\/ventricular arrhythmias\u003c\/li\u003e\n\u003cli\u003eRecognize the clinical contributions from different sub-specialists when caring for these patients\u003c\/li\u003e\n\u003cli\u003eDevelop a mechanism to identify patients with advanced amyloidosis who could benefit from clinical trials and advanced therapeutics\u003c\/li\u003e\n\u003cli\u003eDiagnose the type of amyloidosis and implement a treatment strategy\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activityAudience\"\u003eAny healthcare provider who cares for patients with amyloidosis. This includes physicians, nurse practitioners, nurses, physician assistants, medical students, and residents\/fellows who specialize in Neurology, Gastroenterology, Hand Surgery, Hematology and Oncology.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAgenda.pdf\u003cbr\u003eAdvances in Positron Emission Tomography (PET) and Amyloidosis.pdf\u003cbr\u003eAL (Light Chain) Amyloidosis Non-Transplant Treatment.pdf\u003cbr\u003eAL (Light Chain) Amyloidosis Pathogenesis and Diagnosis.pdf\u003cbr\u003eCardiac Electrophysiology and Amyloidosis.pdf\u003cbr\u003eCardiac Imaging Echocardiography.pdf\u003cbr\u003eCardiac Imaging Nuclear Imaging Modalities.pdf\u003cbr\u003eCreating and Developing an Amyloidosis Clinic.pdf\u003cbr\u003eGastrointestinal Manifestations of Amyloidosis.pdf\u003cbr\u003eNeurological Manifestations of Amyloidosis.pdf\u003cbr\u003eNew and Ongoing Clinical Trials in Amyloidosis NYULH Experience 1.pdf\u003cbr\u003eNew and Ongoing Clinical Trials in Amyloidosis NYULH Experience 2.pdf\u003cbr\u003eOrthopedic and Musculoskeletal Manifestations of Amyloidosis.pdf\u003cbr\u003eRenal Manifestations of Amyloidosis.pdf\u003cbr\u003eRole of Cardiac Magnetic Resonance Imaging (MRI) in Amyloidosis.pdf\u003cbr\u003eThe Future of Amyloidosis Treatment Gene Editing and Antibody Therapy.pdf\u003cbr\u003eTransthyretin Amyloidosis Emphasis on Cardiomyopathy.pdf\u003cbr\u003eSeptember 19.mp4 (8 hours 48 minutes)\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954452369506,"sku":"MED-AMB03875","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/NYU-Langone-Health-Cardiac-Amyloidosis-Diagnosis-and-Novel-Therapeutics-in-2024.jpg?v=1779377162","url":"https:\/\/meducourse.com\/products\/nyu-langone-health-cardiac-amyloidosis-diagnosis-and-novel-therapeutics-in-2024","provider":"Meducourse","version":"1.0","type":"link"}